迈瑞医疗1月5日获融资买入2.86亿元，融资余额38.05亿元

Summary of Key Points Core Viewpoint - On January 5, 2025, Mindray Medical saw a stock increase of 4.80% with a trading volume of 3.339 billion yuan, indicating strong market interest despite a net financing outflow of 100 million yuan on that day [1]. Group 1: Financial Performance - For the period from January to September 2025, Mindray Medical reported a revenue of 25.834 billion yuan, reflecting a year-on-year decrease of 12.38% [2]. - The net profit attributable to shareholders for the same period was 7.570 billion yuan, down 28.83% year-on-year [2]. Group 2: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for Mindray Medical reached 108,800, an increase of 18.86% compared to the previous period [2]. - The average number of circulating shares per shareholder was 11,139, which decreased by 15.87% from the previous period [2]. Group 3: Financing and Margin Trading - On January 5, 2025, Mindray Medical had a total margin trading balance of 3.866 billion yuan, with a financing balance of 3.805 billion yuan, accounting for 1.57% of the circulating market value [1]. - The company’s margin trading balance is above the 80th percentile of the past year, indicating a high level of trading activity [1]. Group 4: Dividend Distribution - Since its A-share listing, Mindray Medical has distributed a total of 35.336 billion yuan in dividends, with 25.025 billion yuan distributed over the last three years [3]. Group 5: Institutional Holdings - As of September 30, 2025, the third-largest circulating shareholder was Hong Kong Central Clearing Limited, holding 117 million shares, a decrease of 14.736 million shares from the previous period [3]. - Other notable institutional shareholders, such as E Fund and Huatai-PB, also reported reductions in their holdings [3].